Amicus Therapeutics Inc. buy StockNews.com
Start price
11.03.23
/
50%
€10.70
Target price
11.03.24
-
Performance (%)
2.80%
End price
12.03.24
€11.00
Summary
This prediction ended on 12.03.24 with a price of €11.00. With a performance of 2.80%, the BUY prediction by StockNews_com for Amicus Therapeutics Inc. closed with a slight gain. StockNews_com has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Amicus Therapeutics Inc. | - | - | - |
iShares Core DAX® | 2.831% | 1.236% | 14.788% |
iShares Nasdaq 100 | 2.918% | 0.640% | 40.290% |
iShares Nikkei 225® | 2.007% | -2.135% | 19.861% |
iShares S&P 500 | 2.257% | 0.451% | 30.090% |
Comments by StockNews_com for this prediction
In the thread Amicus Therapeutics Inc. diskutieren
Amicus Therapeutics, Inc. (NASDAQ: FOLD) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for FOLD provided by MarketBeat
In the thread Trading Amicus Therapeutics Inc.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten